February 2018

Charges for oncology services vary widely across hospitals and impose financial burdens. Further legislation is needed to address disparities in access to high-quality cancer care.

Discussion of current literature regarding the impact of telephonically delivered comprehensive medication reviews on patient outcomes, including mortality rates, hospital readmission rates, and healthcare expenditures.

A health insurance claims-based risk assessment tool to predict patients’ first severe chronic obstructive pulmonary disease exacerbation has been developed and validated.

We developed short patient experience surveys that were sensitive to our broad quality initiative, were meaningful and acceptable to patients, and had good response rates.

Patients with diabetes receiving insulin treatment with lower cost sharing for blood glucose testing strips were more likely to achieve glycemic control than those with higher cost sharing.

Super-utilizers place a significant clinical and financial burden on the healthcare system. The authors investigated the effectiveness of community navigators in reducing hospital utilization and costs.

Premiums in federally facilitated Affordable Care Act Health Insurance Marketplaces are higher in geographic areas with more concentrated hospitals and physician practices and fewer insurers.

The annual price of monoclonal antibody therapies used in oncology and hematology is about $100,000 higher than those used in other disease states.

Centrally assisted collaborative telecare is a cost-effective strategy relative to usual care for treating posttraumatic stress disorder and depression in the Military Health System.

Despite the high level of hospital adoption of electronic health records and the federal incentives to do so, the most common type of data breach in hospitals occurred with paper records and films.